Search

Your search keyword '"Middeldorp, S."' showing total 1,250 results

Search Constraints

Start Over You searched for: Author "Middeldorp, S." Remove constraint Author: "Middeldorp, S."
1,250 results on '"Middeldorp, S."'

Search Results

51. Long-term (180-day) outcomes in critically ill patients with COVID-19 in the REMAP-CAP randomized clinical trial

52. Non-invasive early exclusion of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: The InShape II study

53. Use of the National Early Warning Score for predicting deterioration of patients with acute pulmonary embolism: a post-hoc analysis of the YEARS Study

58. Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction in women with a history: a randomized trial

59. Lupus anticoagulant associates with thrombosis in patients with COVID-19 admitted to intensive care units

60. SARS-CoV-2 Vaccine and Thrombosis: An Expert Consensus on Vaccine-Induced Immune Thrombotic Thrombocytopenia

63. Age-Stratified Risk of Cerebral Venous Sinus Thrombosis After SARS-CoV-2 Vaccination

64. Hematoma Expansion and Clinical Outcomes in Patients With Factor-Xa Inhibitor-Related Atraumatic Intracereoral Hemorrhage Treated Within the ANNEXA-4 Trial Versus Real-World Usual Care

65. Pregnancy outcomes in women with Budd-Chiari syndrome or portal vein thrombosis - a multicentre retrospective cohort study

66. Growth differentiation factor-15 for prediction of bleeding in cancer patients

67. Splanchnic vein thrombosis-related mortality in the Veneto region (Italy), 2008-2019: Retrospective analysis of epidemiological data

68. Thrombophilia, Thrombosis and Thromboprophylaxis in Pregnancy: For What and in Whom?

69. Interne geneeskunde, fundament voor de toekomst

70. Declining mortality of cerebral venous sinus thrombosis with thrombocytopenia after SARS-CoV-2 vaccination

71. Women's representation in venous thromboembolism randomized trials and registries: The illustrative example of direct oral anticoagulants for acute treatment

72. Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.

73. Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial

74. Postthrombotic syndrome and quality of life after deep vein thrombosis in patients treated with edoxaban versus warfarin

75. Differences in thrombin and plasmin generation potential between East African and Western European adults: The role of genetic and non-genetic factors

76. ESHRE guideline: recurrent pregnancy loss: an update in 2022

77. Hyperemesis gravidarum and vitamin K deficiency: a systematic review

78. Second consensus document on diagnosis and management of acute deep vein thrombosis: updated document elaborated by the ESC Working Group on aorta and peripheral vascular diseases and the ESC Working Group on pulmonary circulation and right ventricular function

79. Diagnostic efficacy of ECG-derived ventricular gradient for the detection of chronic thromboembolic pulmonary hypertension in patients with acute pulmonary embolism

80. Home Treatment Compared to Initial Hospitalization in Normotensive Patients with Acute Pulmonary Embolism in the Netherlands: A Cost Analysis

81. Prediction of chronic thromboembolic pulmonary hypertension with standardised evaluation of initial computed tomography pulmonary angiography performed for suspected acute pulmonary embolism

84. Risk of venous thromboembolism in women with endometriosis

85. Transgender Medicine and Risk of Venous Thromboembolism

86. Outcomes of Cerebral Venous Thrombosis due to Vaccine-Induced Immune Thrombotic Thrombocytopenia After the Acute Phase

87. Risk of recurrence in women with venous thromboembolism related to estrogen-containing contraceptives: Systematic review and meta-analysis

88. Management of Cerebral Venous Thrombosis Due to Adenoviral COVID-19 Vaccination

89. A short review of ciraparantag in perspective of the currently available anticoagulant reversal agents

91. Effect of polypharmacy on bleeding with rivaroxaban versus vitamin K antagonist for treatment of venous thromboembolism

92. Post-thrombotic syndrome after upper extremity deep vein thrombosis: An international Delphi consensus study

93. ISTH guidelines for antithrombotic treatment in COVID-19

94. Lupus anticoagulant associates with thrombosis in patients with COVID-19 admitted to intensive care units: A retrospective cohort study

96. Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial

97. Andexanet Alfa for Specific Anticoagulation Reversal in Patients with Acute Bleeding during Treatment with Edoxaban

98. The role of the intestinal microbiome in antiphospholipid syndrome

99. Pregnancy outcomes in women with Budd–Chiari syndrome or portal vein thrombosis – a multicentre retrospective cohort study

Catalog

Books, media, physical & digital resources